Catabasis names Rick Modi chief business officer
This article was originally published in Scrip
Catabasis Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics using its SMART linker technology platform, has named Rick Modi chief business officer. Prior to joining Catabasis, Mr Modi was senior vice-president, global marketing at InterMune, an orphan drug company that was acquired by Roche in 2014.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.